Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Rennie Ice chewable tablets
010102100BBBCAF
|
Proprietary compound preparation BNF 0101021 | Compound alginates and proprietary indigestion preparations | Gastro-Intestinal System | 12 |
|
Atropine 500micrograms/5ml oral solution
0102000ACAABABA
|
Atropine sulfate (Oral) | Atropine sulfate | Gastro-Intestinal System | 11 |
|
Co-simalcite 125mg/500mg/5ml oral suspension sugar free
0101010P0AAAAAA
|
Co-simalcite | Co-simalcite (Simeticone/hydrotalcite) | Gastro-Intestinal System | 11 |
|
Sod dihydrogen phos 542mg/Disod hydrogen phos 240mg/ml soln
0106050U0AAAAAA
|
Phosphates | Phosphates | Gastro-Intestinal System | 11 |
|
Gaviscon Double Action Liquid mixed berries
0101021B0BEBGA0
|
Gaviscon | Alginic acid compound preparations | Gastro-Intestinal System | 10 |
|
Senokot 7.5mg tablets 12 Years Plus (Forum)
0106020M0BBAEAC
|
Senokot (Senna) | Senna | Gastro-Intestinal System | 10 |
|
Zantac 150mg tablets
0103010T0BBAAAA
|
Zantac | Ranitidine hydrochloride | Gastro-Intestinal System | 10 |
|
Allantoin 10.25mg / Lidocaine 10.25mg suppositories
0107010N0AAAFAF
|
Lidocaine hydrochloride (Rectal) | Lidocaine hydrochloride | Gastro-Intestinal System | 9 |
|
Calcium carb 680mg/Magnesium carb heavy 80mg chew tab
010102100AAAFAF
|
Generic compound preparation BNF 0101021 | Compound alginates and proprietary indigestion preparations | Gastro-Intestinal System | 9 |
|
Calcium carbonate 120mg/5ml oral suspension
0101021C0AACWCW
|
Calcium carbonate (Antacid) | Calcium carbonate | Gastro-Intestinal System | 9 |
|
Calcium carbonate 250mg/5ml oral suspension
0101021C0AACECE
|
Calcium carbonate (Antacid) | Calcium carbonate | Gastro-Intestinal System | 9 |
|
Generic Creon 10000 gastro-resistant capsules
0109040N0AAAUAU
|
Pancreatin | Pancreatin | Gastro-Intestinal System | 9 |
|
Sucralfate 250mg/5ml oral suspension
0103030S0AAACAC
|
Sucralfate (Systemic) | Sucralfate | Gastro-Intestinal System | 9 |
|
Bidex 84mg/ml oral solution
0101012B0BLAAAB
|
Bidex | Sodium bicarbonate | Gastro-Intestinal System | 8 |
|
Hydrocortisone 10% foam aerosol enema
0105020B0AAAAAA
|
Hydrocortisone acetate (Rectal) | Hydrocortisone acetate | Gastro-Intestinal System | 8 |
|
Peppermint oil liquid
0102000T0AAABAB
|
Peppermint oil | Peppermint oil | Gastro-Intestinal System | 8 |
|
Altacite Plus oral suspension
0101010P0BBAAAA
|
Altacite Plus | Co-simalcite (Simeticone/hydrotalcite) | Gastro-Intestinal System | 7 |
|
Bisacodyl 5mg/5ml oral suspension
0106020C0AAALAL
|
Bisacodyl | Bisacodyl | Gastro-Intestinal System | 7 |
|
Colifoam 10% aerosol
0105020B0BBAAAA
|
Colifoam | Hydrocortisone acetate | Gastro-Intestinal System | 7 |
|
Colomint 0.2ml gastro-resistant capsules
0102000T0BJAAAA
|
Colomint | Peppermint oil | Gastro-Intestinal System | 7 |
|
Esomeprazole 40mg/5ml oral suspension
0103050E0AAADAD
|
Esomeprazole | Esomeprazole | Gastro-Intestinal System | 7 |
|
Glycopyrronium bromide 3mg/5ml oral liquid
0102000L0AAAHAH
|
Glycopyrronium bromide (Oral) | Glycopyrronium bromide | Gastro-Intestinal System | 7 |
|
Rennie Extra chewable tablets
010102100BBAZA0
|
Proprietary compound preparation BNF 0101021 | Compound alginates and proprietary indigestion preparations | Gastro-Intestinal System | 7 |
|
Asacol 500mg suppositories
0105010B0BBACAB
|
Asacol | Mesalazine (Systemic) | Gastro-Intestinal System | 6 |
|
Budenofalk 4mg suppositories
0105020A0BCADAI
|
Budenofalk | Budesonide | Gastro-Intestinal System | 6 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.